Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Essential oil of lavender in anxiety disorders: Ready for prime time?

Malcolm BJ, Tallian K.

Ment Health Clin. 2018 Mar 26;7(4):147-155. doi: 10.9740/mhc.2017.07.147. eCollection 2017 Jul.

2.

Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.

Möller HJ, Volz HP, Dienel A, Schläfke S, Kasper S.

Eur Arch Psychiatry Clin Neurosci. 2017 Nov 17. doi: 10.1007/s00406-017-0852-4. [Epub ahead of print]

PMID:
29150713
3.

Silexan in anxiety disorders: Clinical data and pharmacological background.

Kasper S, Müller WE, Volz HP, Möller HJ, Koch E, Dienel A.

World J Biol Psychiatry. 2018 Sep;19(6):412-420. doi: 10.1080/15622975.2017.1331046. Epub 2017 Jun 19. Review.

PMID:
28511598
4.

Effectiveness of Silexan oral lavender essential oil compared to inhaled lavender essential oil aromatherapy on sleep in adults: a systematic review protocol.

Greenberg MJ, Slyer JT.

JBI Database System Rev Implement Rep. 2017 Apr;15(4):961-970. doi: 10.11124/JBISRIR-2016-002980. Review.

PMID:
28398982
5.

Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set.

Kasper S, Möller HJ, Volz HP, Schläfke S, Dienel A.

Int Clin Psychopharmacol. 2017 Jul;32(4):195-204. doi: 10.1097/YIC.0000000000000176.

PMID:
28379882
6.

Silexan does not cause withdrawal symptoms even when abruptly discontinued.

Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A, Kasper S.

Int J Psychiatry Clin Pract. 2017 Sep;21(3):177-180. doi: 10.1080/13651501.2017.1301488. Epub 2017 Mar 20.

PMID:
28319423
7.

Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis.

Generoso MB, Soares A, Taiar IT, Cordeiro Q, Shiozawa P.

J Clin Psychopharmacol. 2017 Feb;37(1):115-117. doi: 10.1097/JCP.0000000000000615. No abstract available.

PMID:
27861196
8.

Efficacy of Silexan in mixed anxiety-depression--A randomized, placebo-controlled trial.

Kasper S, Volz HP, Dienel A, Schläfke S.

Eur Neuropsychopharmacol. 2016 Feb;26(2):331-340. doi: 10.1016/j.euroneuro.2015.12.002. Epub 2015 Dec 12.

PMID:
26718792
9.

Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.

Kasper S, Anghelescu I, Dienel A.

Eur Neuropsychopharmacol. 2015 Nov;25(11):1960-7. doi: 10.1016/j.euroneuro.2015.07.024. Epub 2015 Aug 7.

PMID:
26293583
10.

Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.

Kasper S.

Wien Med Wochenschr. 2015 Jun;165(11-12):217-28. doi: 10.1007/s10354-015-0360-y. Epub 2015 Jun 20.

PMID:
26092515
11.

[Acute pharmacotherapy for anxiety symptoms in patients with depression].

Quante A.

Fortschr Neurol Psychiatr. 2015 Mar;83(3):142-8. doi: 10.1055/s-0034-1399243. Epub 2015 Mar 20. Review. German.

PMID:
25794319
12.

Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.

Baldinger P, Höflich AS, Mitterhauser M, Hahn A, Rami-Mark C, Spies M, Wadsak W, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu063. doi: 10.1093/ijnp/pyu063.

13.

No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.

Heger-Mahn D, Pabst G, Dienel A, Schläfke S, Klipping C.

Drugs R D. 2014 Dec;14(4):265-72. doi: 10.1007/s40268-014-0065-5.

14.

Lavender oil preparation Silexan is effective in generalized anxiety disorder--a randomized, double-blind comparison to placebo and paroxetine.

Kasper S, Gastpar M, Müller WE, Volz HP, Möller HJ, Schläfke S, Dienel A.

Int J Neuropsychopharmacol. 2014 Jun;17(6):859-69. doi: 10.1017/S1461145714000017. Epub 2014 Jan 23.

PMID:
24456909
15.

An orally administered lavandula oil preparation (Silexan) for anxiety disorder and related conditions: an evidence based review.

Kasper S.

Int J Psychiatry Clin Pract. 2013 Nov;17 Suppl 1:15-22. doi: 10.3109/13651501.2013.813555. Epub 2013 Aug 3. Review.

PMID:
23808618
16.

Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels.

Schuwald AM, Nöldner M, Wilmes T, Klugbauer N, Leuner K, Müller WE.

PLoS One. 2013 Apr 29;8(4):e59998. doi: 10.1371/journal.pone.0059998. Print 2013.

17.

Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers.

Doroshyenko O, Rokitta D, Zadoyan G, Klement S, Schläfke S, Dienel A, Gramatté T, Lück H, Fuhr U.

Drug Metab Dispos. 2013 May;41(5):987-93. doi: 10.1124/dmd.112.050203. Epub 2013 Feb 11.

18.

Characterization of anxiolytic and neuropharmacological activities of Silexan.

Kumar V.

Wien Med Wochenschr. 2013 Feb;163(3-4):89-94. doi: 10.1007/s10354-012-0164-2. Epub 2013 Jan 30. Review.

PMID:
23361848
19.

Silexan, an essential oil from flowers of Lavandula angustifolia, is not recognized as benzodiazepine-like in rats trained to discriminate a diazepam cue.

Silenieks LB, Koch E, Higgins GA.

Phytomedicine. 2013 Jan 15;20(2):172-7. doi: 10.1016/j.phymed.2012.10.004. Epub 2012 Nov 30.

PMID:
23207249
20.

Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder.

Uehleke B, Schaper S, Dienel A, Schlaefke S, Stange R.

Phytomedicine. 2012 Jun 15;19(8-9):665-71. doi: 10.1016/j.phymed.2012.02.020. Epub 2012 Apr 3.

PMID:
22475718

Supplemental Content

Loading ...
Support Center